Congratulations to Implanet !
Implanet, founded in 2007 and based in Bordeaux, France. The company's flagship products include the JAZZ® spinal implant, which is designed to enhance spinal fusion procedures, and the MADISON knee implant.
In 2023, Implant's gross sales are $8M in annual sales and lost -$8M in earnings. In other words, it cost Implanet $16M to make $8M in sales. Seven years after their IPO, their market cap is worth $14M.
They have no financial leverage. They cannot go public again.
Seriously, you and I could do better by opening up a donut shop.
OrthoWorld shared the newest FDA clearance from Implant below...
Implanet announced FDA 510(k) clearance to market its new hybrid fixation system Jazz Spinal System.
As a result of the technological partnership established in 2022 with Sanyou Medical, this Jazz Spinal System features a comprehensive solution of pedicle screws, combined with the JAZZ Band implant range. Jazz Spinal System includes a complete system for the treatment of pediatric deformity as well as a comprehensive range of solutions for treating adult spinal pathologies, including minimally invasive approaches. Designed for both traditional ope...
